Twist Bioscience Corporation
TWST
$39.96
$0.842.15%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 270.83M | 276.40M | 289.42M | 293.34M | 311.14M |
Total Receivables | 39.32M | 34.90M | 32.99M | 37.09M | 35.35M |
Inventory | 23.52M | 24.08M | 28.48M | 30.38M | 30.86M |
Prepaid Expenses | 11.65M | 11.40M | 10.94M | 11.06M | 12.87M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 345.31M | 346.78M | 361.83M | 371.87M | 390.23M |
|
|||||
Total Current Assets | 345.31M | 346.78M | 361.83M | 371.87M | 390.23M |
Net Property, Plant & Equipment | 157.14M | 161.35M | 167.62M | 185.01M | 195.32M |
Long-term Investments | 85.81M | 85.81M | 85.81M | 85.81M | 85.81M |
Goodwill | 85.81M | 85.81M | 85.81M | 85.81M | 85.81M |
Total Other Intangibles | 14.22M | 14.48M | 14.74M | 51.90M | 53.19M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 6.10M | 5.91M | 8.12M | 8.26M | 8.27M |
Total Assets | 608.58M | 614.32M | 638.12M | 702.85M | 732.82M |
|
|||||
Total Accounts Payable | 7.50M | 1.63M | 6.63M | 7.70M | 9.26M |
Total Accrued Expenses | 41.87M | 48.75M | 46.50M | 39.73M | 34.75M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 15.03M | 14.81M | 14.56M | 14.62M | 14.81M |
Total Finance Division Other Current Liabilities | 5.24M | 5.82M | 6.08M | 5.44M | 6.42M |
Total Other Current Liabilities | 5.24M | 5.82M | 6.08M | 5.44M | 6.42M |
Total Current Liabilities | 69.65M | 71.01M | 73.76M | 67.49M | 65.23M |
|
|||||
Total Current Liabilities | 69.65M | 71.01M | 73.76M | 67.49M | 65.23M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 67.59M | 70.22M | 72.63M | 74.80M | 77.07M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 15.41M | 407.00K | 597.00K | 421.00K | 475.00K |
Total Liabilities | 152.64M | 141.63M | 146.98M | 142.72M | 142.77M |
|
|||||
Common Stock & APIC | 1.73B | 1.72B | 1.70B | 1.68B | 1.67B |
Retained Earnings | -1.27B | -1.24B | -1.21B | -1.12B | -1.08B |
Treasury Stock & Other | -649.00K | -522.00K | -735.00K | -660.00K | -565.00K |
Total Common Equity | 455.94M | 472.69M | 491.14M | 560.13M | 590.04M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 455.94M | 472.69M | 491.14M | 560.13M | 590.04M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 455.94M | 472.69M | 491.14M | 560.13M | 590.04M |
|